期刊文献+

COX-2基因单核苷酸多态性与肝细胞癌关联的研究 被引量:6

Association of COX-2 gene SNPs with the risk of hepatocellular carcinoma
原文传递
导出
摘要 目的:探讨广西地区COX-2基因-1195G〉A(rs689466)和8473T〉C(rs5275)位点单核苷酸多态性与肝细胞癌(HCC)遗传易感性的关系。方法:采用以医院为基础的病例对照研究方法。研究对象为780例经组织学确诊的HCC患者和780例相同地区、年龄、性别和民族频数匹配的非肿瘤患者。运用TaqManMGB探针等位基因分型技术进行COX-2基因单核苷酸多态性的检测,以X^2检验和非条件Logistic回归模型分析比较病例和对照两组间各位点基因型频率分布的差异及其与HCC患病风险的关系,并进一步探讨基因-环境的交互作用对HCC患病风险的影响。结果:COX-2基因单位点-1195G〉A或8473T〉C多态与HCC患病风险无统计学相关性(显性模型下SNP-1195G〉A:校正OR-1.32,95%CI:0.94~1.85;SNP8473T〉C:校正OR-0.87,95%CI:0.64~1.18)。分层分析显示,显性模型下COX-2基因-1195G〉A位点GA+AA基因型增加年龄〈55岁者患HCC的风险(校正OR=1.56,95%CI:1.03~2.37),而8473T〉C位点TC+CC基因型可降低女性患HCC的风险(校正OR=0.50,95%CI:0.25~0.99)。进一步交互作用分析显示,COX-2基因-1195G〉A位点与年龄、8473T〉C位点与性别分别存在交互作用(P=0.002;P=0.007)。结论:COX-2基因-1195G〉A或8473T〉C位点SNP的单独效应可能与HCC易感性无关联,但是-1195G〉A与年龄、8473T〉C位点与性别存在交互作用,影响HCC的患病风险。 OBJECTIVE:To explore the relationship of COX-2 polymorphisms -1195G〉A (rs689466) and 8473T 〉C (rs5275) with the susceptibility to hepatocellular carcinoma (HCC). METHODS: A hospital-based case-control study was conducted in 780 newly and histopathologically diagnosed cases with HCC and 780 cancer-free controls frequency-matched for age, sex, nationality and residence. Genotypes of COX-2 were detected using applied biosystems TaqMan genotyping platform. Unconditional Logistic regression model and X^2 test were used to evaluate the different genotypes distribution and associations with HCC risk, respectively. RESULTS: The variant genotypes of both COX-2 -1195G〉A (adjusted OR=1. 32, 95%CI:0.94- 1.85) and 8473T〉C (adjusted OR=0.87, 95%CI:0.64-1.18) polymorphisms were not significantly associated with the risk of HCC. However, the stratified analysis revealed that under a dominant model the --1195GA+ AA genotypes increased the risk of HCC among the youngers (less than 55 years old, adjusted OR= 1. 56, 95%CI:1. 03-2. 37), 8473T〉C TC+CC genotypes decreased the risk of HCC among females (adjusted OR=0. 50, 95MCI:0.25-0. 99). The interactions between --1195G〉A polymorphisms and age, 8473T〉C polymorphisms and sex might modify the risk of HCC (P = 0. 002, P = 0. 007). CONCLUSIONS: COX-2 -1195G〉 A and 8473T〉 C polymorphisms do not have the independent effects for the susceptibility to HCC, but the interactions between genetic polymorphisms of -1195G〉A and age, 8473T〉C and sex may modify the risk of HCC.
出处 《中华肿瘤防治杂志》 CAS 2011年第6期405-409,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 广西自然科学基金(桂科自0832017Z) 国家自然科学基金(30860247) 广西大型仪器协作网测试补助(912-2009-116)
关键词 肝细胞 基因 COX-2 单核苷酸多态性 交互作用 carcinoma, hepatocellular genes,COX 2 single nucleotide polymorphism interaction
  • 相关文献

参考文献16

  • 1Aravalli R N, Steer C J, Cressman E N. Molecular mechanisms of hepatocellular carcinoma[J]. Hepatology, 2008, 48(6) : 2047- 2063.
  • 2Giannitrapani L, Ingrao S, Soresi M, et al. Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study[J]. Ann N Y Acad Sci, 2009, 1155 : 293-299.
  • 3Wang D, Mann J R, DuBois R N. The role of prostaglandins and other eieosanoids in the gastrointestinal traet[J]. Gastroenterology, 2005,128(5): 1445-1461.
  • 4Braeuer R R, Zigler M, Villares G J, et al. Transcriptional control of melanoma metastasis: The importance of the tumor microenvironment[J].Semin Cancer Biol, 2011,21 (2) : 83-88.
  • 5Zhang X M, Miao X P, Tan W, et al. Identification of functional genetic variants in cyelooxygenase-2 and their association with risk of esophageal cancer[J]. Gastroenterology, 2005, 129(2): 565-576.
  • 6Akkiz H, Bayram S, Bekar A, et al. Functional polymorphisms of cyclooxygenase-2 gent and risk for hepatocellular carcinoma [J]. Mol Cell Biochem, 2011, 347(1-2):201-208.
  • 7许东奎,张雪梅,赵平,蔡建春,赵丹,谭文,郭永丽,林东昕.COX-2基因启动子区单核苷酸多态与肝癌遗传易感性的关系[J].中华肝胆外科杂志,2008,14(12):840-843. 被引量:5
  • 8Yang H, Gu J, Lin X, et al. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition[J]. Clin Cancer Res, 2008, 14(7) ;2236-2244.
  • 9Gangwar R, Mandhani A, Mittal R D, et al. Functional poly morphisms of eyclooxygenase-2 (COX-2) gene and risk for uri nary bladder cancer in North India[J]. Surgery, 2011, 149(1) 126-134.
  • 10Campa D, Zienolddiny S, Maggini V, et al. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer[J]. Carcinogenesis, 2004, 25 (2) : 229-235.

二级参考文献12

  • 1Dong-ShengHuang Ke-ZhenShen Jian-FengWei Thng-BoLiang Shu-SenZheng Hai-YangXie.Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2[J].World Journal of Gastroenterology,2005,11(2):204-207. 被引量:31
  • 2Ning-Bo Liu,Tao Peng,Chao Pan,Yu-Yu Yao,Bo Shen,Jing Leng.Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis[J].World Journal of Gastroenterology,2005,11(40):6281-6287. 被引量:20
  • 3Duell EJ,WienckeJ K,Cheng T J, et al. Polymorphismsin the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells[J]. Carcinogenesis. 2000,21 (5) :965-971.
  • 4Kanaar R. Hoeijmakers J H, Van Gem D. Molecular mechanisms of DNA double-stranded repair[J]. Trends Cell Biol, 1998,8(12):483-489.
  • 5Butkiewicz D, Rusin M, Enewold L,et al. Genetic polymorphisms in DNA repair genes and risk of lung calcer[J]. Carcinogenesis.2001. 22(4): 593-597.
  • 6Wang Y F, Liang D, Spitz M R, et al. XRCC3 genetic polymorphism, smoking and lung carcinoma risk in minority populations [J]. Cancer, 2003, 98(8): 1701-1706.
  • 7Matullo G. GuarreraS, CarturanS. et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study[J] . Int J Cancer, 2001 92(4): 562-567.
  • 8Han S. Zhang H T, Wang Z, et al. DNA repair gene XRCC3 polymorphisms and cancer risk, a recta-analysis of 48 case-con trol studies[J].Eur J Hum Genet, 2006, 14(10): 1136-1144.
  • 9Lee S A, Lee K M, Park S K, et al, Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case control study in Korean women and meta-analysisof 12 studies[J]. Breast Cancer Res Treat. 2007, 103(1):71 76.
  • 10Jacobsen N R. Raasehou Nielsen O, Nexo B, et al. XRCC3 polymorphisms and risk of lung cancer [J]. Cancer Lett, 2004. 213(1): 67 75.

共引文献11

同被引文献67

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部